CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+7.34%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$6.59B
AUM Growth
+$6.59B
(+12%)
Cap. Flow
+$266M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
67.98%
Holding
142
New
14
Increased
47
Reduced
57
Closed
13
Top Buys
| 1 |
Visa
V
|
$48M |
| 2 |
Microsoft
MSFT
|
$42.7M |
| 3 |
Thermo Fisher Scientific
TMO
|
$38.8M |
| 4 |
Ecolab
ECL
|
$37.9M |
| 5 |
FRC
First Republic Bank
FRC
|
$34.6M |
Top Sells
| 1 |
HDFC Bank
HDB
|
$105M |
| 2 |
Philip Morris
PM
|
$21.5M |
| 3 |
Meta Platforms (Facebook)
META
|
$11.6M |
| 4 |
CELG
Celgene Corp
CELG
|
$10.4M |
| 5 |
Merck
MRK
|
$8.98M |
Sector Composition
| 1 | Financials | 26.2% |
| 2 | Healthcare | 18.75% |
| 3 | Consumer Discretionary | 17.75% |
| 4 | Communication Services | 14.57% |
| 5 | Materials | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Bausch Health
BHC
$2.77B
| $3.41M | 0.05% |
197,010
-17,011
| -8% | -$294K |
|
|
ONCE
77
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $3.12M | 0.05% |
52,281
+7,449
| +17% | +$445K |
|
78
Supernus Pharmaceuticals
SUPN
$2.52B
| $3.09M | 0.05% |
71,670
-64,602
| -47% | -$2.78M |
|
|
OXFD
79
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $3.06M | 0.05% |
182,148
+6,030
| +3% | +$101K |
|
|
SIOX
80
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $3.05M | 0.05% |
131,500
+21,900
| +20% | +$508K |
|
|
SPNC
81
DELISTED
Spectranetics Corp
SPNC
| $2.81M | 0.04% |
73,180
+6,974
| +11% | +$268K |
|
|
NDRM
82
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $2.78M | 0.04% |
+92,800
| New | +$2.78M |
|
|
CEMP
83
DELISTED
Cempra, Inc.
CEMP
| $2.73M | 0.04% |
592,946
-61,965
| -9% | -$285K |
|
|
GWPH
84
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.72M | 0.04% |
27,098
+4,072
| +18% | +$408K |
|
|
ITCI
85
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.71M | 0.04% |
217,962
+30,139
| +16% | +$374K |
|
86
Acadia Healthcare
ACHC
$2.17B
| $2.67M | 0.04% |
+54,000
| New | +$2.67M |
|
87
Aclaris Therapeutics
ACRS
$219M
| $2.62M | 0.04% |
96,600
+15,100
| +19% | +$410K |
|
|
TVRD
88
Tvardi Therapeutics, Inc. Common Stock
TVRD
$272M
| $2.54M | 0.04% |
165,011
-49,573
| -23% | -$763K |
|
89
Toronto Dominion Bank
TD
$128B
| $2.44M | 0.04% |
37,332
| – | – |
|
|
ELGX
90
DELISTED
Endologix Inc
ELGX
| $2.44M | 0.04% |
501,006
-23,550
| -4% | -$114K |
|
91
Insmed
INSM
$30.6B
| $2.43M | 0.04% |
141,471
+19,021
| +16% | +$326K |
|
92
Mastercard
MA
$536B
| $2.41M | 0.04% |
19,819
-8,481
| -30% | -$1.03M |
|
|
HIND
93
Vyome Holdings, Inc. Common Stock
HIND
$227M
| $2.41M | 0.04% |
242,893
+45,088
| +23% | +$447K |
|
94
NeoGenomics
NEO
$1.1B
| $2.2M | 0.03% |
+246,000
| New | +$2.2M |
|
95
Snap-on
SNA
$16.8B
| $2M | 0.03% |
12,677
+3,760
| +42% | +$594K |
|
|
STOR
96
DELISTED
STORE Capital Corporation
STOR
| $1.91M | 0.03% |
84,911
+19,915
| +31% | +$447K |
|
97
CVS Health
CVS
$93B
| $1.81M | 0.03% |
22,470
| – | – |
|
98
Aramark
ARMK
$10.2B
| $1.7M | 0.03% |
+41,600
| New | +$1.7M |
|
99
Ingredion
INGR
$8.19B
| $1.63M | 0.02% |
13,700
| – | – |
|
|
VLRX
100
DELISTED
VALERITAS HOLDINGS INC
VLRX
| $1.6M | 0.02% |
+233,952
| New | +$1.6M |
|